PROPORSI RESISTENSI GANDA (MDR) TB PARU DI KABAUPATEN DAN KOTA PEKALONGAN BERDASARKAN SURVEY
| Main Authors: | Gitawati, Retno; Puslitbang Biomedis dan Farmasi, Balitbangkes, Isnawati, Ani; Puslitbang Biomedis dan Farmasi, Balitbangkes, Raini, Mariana; Puslitbang Biomedis dan Farmasi, Balitbangkes |
|---|---|
| Other Authors: | BADAN LITBANGKES KEMENKES |
| Format: | Article Book eJournal |
| Bahasa: | ind |
| Terbitan: |
Pusat Humaniora, Kebijakan Kesehatan dan Pemberdayaan Masyarakat
, 2012
|
| Online Access: |
http://ejournal.litbang.depkes.go.id/index.php/hsr/article/view/1888 |
Daftar Isi:
- Multi-drug resistant (MDR) on tuberculosis (TB) becomes a threatening in the world, especially with the increasing of Human Immunodeficiency Virus/Auto Immune Disease Syndroms (HIV/AIDS) cases. And for Indonesia, this could become a new public health problem. The Global Surveillance data on anti-tuberculosis drugs showed the MDR varied 0% to 22.1%. Indonesia is one of Asian countries that has not contributed to MDR data because the Indonesia (TB) Control Program has no accurate and neither recognized data. This research aimed to determine the proportion of MDR on TB. It was a cross sectional survey on Micobacterium tuberculosis resistance anti-tuberculosis drugs conducted in Pekalongan District and Pekalongan Municipality. We examined 200 patients' sputum by sputum smears and who had clinically TB positive. They were from all Health Centers (Pusat Kesehatan Masyarakat) that implemented the TB program by TB treatment with DOTS (Directly Observed Treatment Shortcourse) strategy recommended in both areas,100% sampling of diagnostic centers. Results showed the proportions of MDR on TB were relatively low, either 2. 1 % in Pekalongan District (Kabupaten) or 4.3% in Pekalongan Municipality. The overall proportion of the MDR on TB in Pekalongan was 2.7%. Key words: tuberculosis, multi-drug resistant, anti-tuberculosis, Directly Observed Treatment Shortcourse